Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
121.34
-1.60 (-1.30%)
At close: Nov 16, 2026, 4:00 PM EST
121.34
0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM EST
Haemonetics Revenue
Haemonetics had revenue of $357.76M in the quarter ending September 26, 2026, with 9.30% growth. This brings the company's total for the last twelve months to $1.38B, up 4.11% year-over-year. In the fiscal year ending March 28, 2026, Haemonetics had annual revenue of $1.33B, down -1.97%. That makes Haemonetics the 6,311th largest company in the world by revenue and 1,574th in the United States.
Revenue (ttm)
$1.38B
Revenue Growth
+4.11%
P/S Ratio
4.00
Revenue / Employee
$459,441
Employees
3,009
Market Cap
5.53B
Revenue by Segment
Fiscal year ended Mar 28, 2026 See the full Haemonetics breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 28, 2026 | 1.33B | -26.80M | -1.97% |
| Mar 29, 2025 | 1.36B | 51.77M | 3.95% |
| Mar 30, 2024 | 1.31B | 140.40M | 12.01% |
| Apr 1, 2023 | 1.17B | 175.46M | 17.67% |
| Apr 2, 2022 | 993.20M | 122.73M | 14.10% |
| Apr 3, 2021 | 870.46M | -118.02M | -11.94% |
| Mar 28, 2020 | 988.48M | 20.90M | 2.16% |
| Mar 30, 2019 | 967.58M | 63.66M | 7.04% |
| Mar 31, 2018 | 903.92M | 17.81M | 2.01% |
| Apr 1, 2017 | 886.12M | -22.72M | -2.50% |
| Apr 2, 2016 | 908.83M | -1.54M | -0.17% |
| Mar 28, 2015 | 910.37M | -28.14M | -3.00% |
| Mar 29, 2014 | 938.51M | 46.52M | 5.22% |
| Mar 30, 2013 | 891.99M | 164.15M | 22.55% |
| Mar 31, 2012 | 727.84M | 51.15M | 7.56% |
| Apr 2, 2011 | 676.69M | 31.26M | 4.84% |
| Apr 3, 2010 | 645.43M | 47.55M | 7.95% |
| Mar 28, 2009 | 597.88M | 81.44M | 15.77% |
| Mar 29, 2008 | 516.44M | 66.83M | 14.86% |
| Mar 31, 2007 | 449.61M | 29.87M | 7.12% |
| Apr 1, 2006 | 419.73M | 36.14M | 9.42% |
| Apr 2, 2005 | 383.60M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bruker | 3.51B |
| Insulet | 3.19B |
| Globus Medical | 3.14B |
| Bio-Rad Laboratories | 2.59B |
| Bio-Rad Laboratories | 2.59B |
| Integer Holdings | 1.83B |
| LivaNova | 1.51B |
| iRhythm Holdings | 854.04M |
HAE News
- 14 hours ago - Haemonetics price target raised to $144 from $115 at Citizens - TheFly
- 3 days ago - Haemonetics initiated with a Buy at Jefferies - TheFly
- 10 days ago - Haemonetics participates in a conference call with JPMorgan - TheFly
- 10 days ago - Haemonetics price target raised to $145 from $140 at Barrington - TheFly
- 10 days ago - Haemonetics price target raised to $165 from $140 at Mizuho - TheFly
- 10 days ago - Haemonetics price target raised to $149 from $123 at Citi - TheFly
- 10 days ago - Haemonetics price target raised to $165 from $142 at Baird - TheFly
- 11 days ago - Haemonetics management to meet with Barrington - TheFly